ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
741.00
-7.50
(-1.00%)
마감 26 1월 1:30AM

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

가격
741.00
매수가
739.75
매도가
742.25
거래량
107
741.00 일간 변동폭 749.50
0.00 52주 범위 0.00
전일 종가
748.50
개장가
749.50
최근 거래 시간
14
@
741
(AT)
마지막 거래 시간
평균 볼륨(3m)
-
재정 규모
797p
VWAP
744.8605

SBEM 최신 뉴스

UBS ETF BLM USD EMMA Sover $ Net Asset Value(s)

UBS ETF BLM USD EMMA Sover $ 24 January 2025   FUND: UBS (Lux) Fund Solutions - Bloomberg USD Emerging Markets Sovereign UCITS ETF ISIN CODE: LU1324516050 DEALING DATE: 01/23/2025 NAV PER...

UBS ETF BLM USD EMMA Sover $ Net Asset Value(s)

UBS ETF BLM USD EMMA Sover $ 23 January 2025   FUND: UBS (Lux) Fund Solutions - Bloomberg USD Emerging Markets Sovereign UCITS ETF ISIN CODE: LU1324516050 DEALING DATE: 01/22/2025 NAV PER...

UBS ETF BLM USD EMMA Sover $ Net Asset Value(s)

UBS ETF BLM USD EMMA Sover $ 22 January 2025   FUND: UBS (Lux) Fund Solutions - Bloomberg USD Emerging Markets Sovereign UCITS ETF ISIN CODE: LU1324516050 DEALING DATE: 01/21/2025 NAV PER...

UBS ETF BLM USD EMMA Sover $ Net Asset Value(s)

UBS ETF BLM USD EMMA Sover $ 22 January 2025   FUND: UBS (Lux) Fund Solutions - Bloomberg USD Emerging Markets Sovereign UCITS ETF ISIN CODE: LU1324516050 DEALING DATE: 01/21/2025 NAV PER...

UBS ETF BLM USD EMMA Sover $ Net Asset Value(s)

UBS ETF BLM USD EMMA Sover $ 21 January 2025   FUND: UBS (Lux) Fund Solutions - Bloomberg USD Emerging Markets Sovereign UCITS ETF ISIN CODE: LU1324516050 DEALING DATE: 01/20/2025 NAV PER...

UBS ETF BLM USD EMMA Sover $ Net Asset Value(s)

UBS ETF BLM USD EMMA Sover $ 20 January 2025   FUND: UBS (Lux) Fund Solutions - Bloomberg USD Emerging Markets Sovereign UCITS ETF ISIN CODE: LU1324516050 DEALING DATE: 01/17/2025 NAV PER...

UBS ETF BLM USD EMMA Sover $ Net Asset Value(s)

UBS ETF BLM USD EMMA Sover $ 17 January 2025   FUND: UBS (Lux) Fund Solutions - Bloomberg USD Emerging Markets Sovereign UCITS ETF ISIN CODE: LU1324516050 DEALING DATE: 01/16/2025 NAV PER...

UBS ETF BLM USD EMMA Sover $ Net Asset Value(s)

UBS ETF BLM USD EMMA Sover $ 16 January 2025   FUND: UBS (Lux) Fund Solutions - Bloomberg USD Emerging Markets Sovereign UCITS ETF ISIN CODE: LU1324516050 DEALING DATE: 01/15/2025 NAV PER...

UBS ETF BLM USD EMMA Sover $ Net Asset Value(s)

UBS ETF BLM USD EMMA Sover $ 15 January 2025   FUND: UBS (Lux) Fund Solutions - Bloomberg USD Emerging Markets Sovereign UCITS ETF ISIN CODE: LU1324516050 DEALING DATE: 01/14/2025 NAV PER...

UBS ETF BLM USD EMMA Sover $ Net Asset Value(s)

UBS ETF BLM USD EMMA Sover $ 14 January 2025   FUND: UBS (Lux) Fund Solutions - Bloomberg USD Emerging Markets Sovereign UCITS ETF ISIN CODE: LU1324516050 DEALING DATE: 01/13/2025 NAV PER...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
EVAXEvaxion Biotech AS
US$ 5.99
(64.56%)
55.41M
ELABPMGC Holdings Inc
US$ 3.0901
(56.07%)
76.48M
PCLAPicoCELA Inc
US$ 4.60
(49.35%)
3.75M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
GODNUGolden Star Acquisition Corporation
US$ 3.11
(-75.82%)
17.51k
GODNGolden Star Acquisition Corporation
US$ 2.93
(-65.67%)
902.76k
NXTTNext Technology Holding Inc
US$ 1.37
(-54.93%)
2.56M
SGLYSingularity Future Technology Ltd
US$ 1.625
(-38.45%)
917.77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90.11
(-38.07%)
8
ACONAclarion Inc
US$ 0.0557
(28.94%)
811.91M
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
RIMEAlgorhythm Holdings Inc
US$ 0.0357
(4.69%)
284.97M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
NVDANVIDIA Corporation
US$ 142.62
(-3.12%)
232.88M
maddyandboomer maddyandboomer 3 분 전
Need a good honest company first before getting what you call good investors....and axxa ain't it....they have shown their colors and resembles red flags...not green $ signs
AXXA
Fire_starter Fire_starter 3 분 전
🔥🔥🔥500 BILLION FOR THE CURE TO CANCER M-RNA VACCINE🔥🔥🔥
RNAZ
Smartypants2 Smartypants2 4 분 전
If jurisdiction was an issue, XTI's lawyers would have brought it as a reason for dismissal previously. Maybe they did -- and the judge already ruled against them. Either way, it's very doubtful it's still an issue in this case.
XERI
jsc52033 jsc52033 4 분 전
but you follow the penny stocks why
BMXI
IcyGalaxy60 IcyGalaxy60 4 분 전
What about 500k down payement for mt.Vernon?
NBRI
gitreal gitreal 5 분 전
I don't invest in scams.
BMXI
doc2016 doc2016 5 분 전
me:



the ban on outgoing messaging from federal agencies should surprise no one. the new administration won this cycle by emphasizing it was time for changes in defense to state to homeland security to treasury to healthcare.meta and data; meta data.
of course
NVDA
jour_trader jour_trader 5 분 전
I believe there is an authorized generic for OxyContin, but that's not quite the same. Once generics are approved the market price will tank, just like Vyvanse will. If Elite were the only one to get the approval that is one thing, but it is not the case. Buying Elite would not stop OxyContin pricin
ELTP
mmayr mmayr 5 분 전
Charlie Rich * Rollin' with the Flow 1977 HQ

[yt]b9_7ByKnwWY[/yt]

https://www.youtube.com/watch?v=b9_7ByKnwWY
StockItOut StockItOut 6 분 전
You're wrong. That's why you hide behind "probably."
XERI
north40000 north40000 6 분 전
Good idea, moms. We have both MNMD and PFE in our portfolios. PFE's expensive acquisition of SGEN(very profitable for us) has been slow to bring enough revenue to the balance sheet to solve PFE's problem being termed a laggard in pharma-land. HLS in Canada terminated a contract with PFE that involve
AMRN MNMD PFE
Ms Labonte Ms Labonte 7 분 전
Next leg up wide open $weet$$
WEET
getmoreshares getmoreshares 7 분 전
Good Afternoon-- catching up on the posts!
Smartypants2 Smartypants2 7 분 전
You don't even know the difference between "knew" and "new," I knew it!
XERI
Monksdream Monksdream 8 분 전
RAIL
https://investorshub.advfn.com/uimage/uploads/2025/1/25/zlxqsIMG_4814.gif
RAIL
misterfishman misterfishman 8 분 전
Be careful the bird like sitting on high voltage lines lol.
IGPK
Steady_T Steady_T 8 분 전
Selection issues for an OLE are many.

There are the drop outs from the original trial. That selects against those who can not tolerate the drug or the titration rate.
There are those that don't choose to go into the OLE for whatever reason. That is self selection.
There
AVXL
Smartypants2 Smartypants2 8 분 전
Once again, you are absolutely incorrect. But at least you are consistent.
XERI
MEPinvest MEPinvest 8 분 전
Do you interpret that as a good thing or a bad thing? Do you think they're being ominous and distressful to investors or cooking up something good for all?
CRTG
misterfishman misterfishman 9 분 전
I hope so. Sometime this year.
IGPK
jsc52033 jsc52033 10 분 전
are you actualy invest in BMXI or is this just boad you can talk on
BMXI
juicyjuice10002 juicyjuice10002 10 분 전
The financial advisor was advised by the insider to buy the shares but that conversation was kept secret. Insider advising the financial advisor is more likely.
FNMA
3331 3331 10 분 전
BIEL: VAGUS NERVE PATENT (PENDING)
NY Post - Jan. 23, 2025
Implantable vagus nerve stimulation (VNS) devices, which can cost $50,000, have long been used to treat epilepsy, depression and stroke. That’s because jolting the vagus nerve — the longest cranial nerve in the body — can help
Monksdream Monksdream 10 분 전
MESO
https://investorshub.advfn.com/uimage/uploads/2025/1/25/rkzrzIMG_4813.gif
MESO

최근 히스토리

Delayed Upgrade Clock